isovitexin has been researched along with galactosamine in 1 studies
Studies (isovitexin) | Trials (isovitexin) | Recent Studies (post-2010) (isovitexin) | Studies (galactosamine) | Trials (galactosamine) | Recent Studies (post-2010) (galactosamine) |
---|---|---|---|---|---|
123 | 0 | 81 | 3,542 | 7 | 704 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, JJ; Lin, MX; Pan, CW; Wang, H | 1 |
1 other study(ies) available for isovitexin and galactosamine
Article | Year |
---|---|
Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation.
Topics: Animals; Apigenin; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Galactosamine; Gene Expression Regulation; Heme Oxygenase-1; Lipopolysaccharides; Liver; Liver Function Tests; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Oryza; Phosphorylation; Plant Extracts; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation | 2018 |